Page last updated: 2024-08-21

hematoxylin and Cancer of Oropharnyx

hematoxylin has been researched along with Cancer of Oropharnyx in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adelstein, DJ; Bishop, JA; Castro, PD; Chernock, RD; Chute, DJ; Corredor, G; Faraji, F; Fu, P; Koyfman, SA; Koyuncu, CF; Lang Kuhs, KA; Lewis, JS; Lu, C; Luo, JR; Madabhushi, A; Mehrad, M; Nag, R; Pan, Q; Sandulache, VC; Sikora, AG; Thompson, LDR; Thorstad, WL; Viswanathan, VS; Wasman, JK; Xu, J; Yang, K; Zhang, Z	1

Other Studies

1 other study(ies) available for hematoxylin and Cancer of Oropharnyx

Article	Year
Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer, 2022, 11-01, Volume: 128, Issue:21 Topics: Alphapapillomavirus; Biomarkers; Carcinoma, Squamous Cell; Eosine Yellowish-(YS); Head and Neck Neoplasms; Hematoxylin; Humans; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck	2022

Article

Year

Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.

Cancer, 2022, 11-01, Volume: 128, Issue:21

Topics: Alphapapillomavirus; Biomarkers; Carcinoma, Squamous Cell; Eosine Yellowish-(YS); Head and Neck Neoplasms; Hematoxylin; Humans; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck

2022